Washington, D.C.

Dec 23, 2014   

  • Commercial Litigation
  • Criminal and forfeiture defense alleging int’l money laundering and unlicensed money transmitting business
  • Administrative litigation FDA alleging misbranding and adulterating autologous stem cells
  • Civil litigation against US involving allegations of Tucker Act violations